小细胞膀胱癌中谱系特异性转录因子定义的分子亚型鉴定
研究探讨小细胞/神经内分泌膀胱癌(SCBC)中谱系特异性转录因子ASCL1、NEUROD1和POU2F3定义的三种分子亚型,类似小细胞肺癌亚型;亚型表达不同水平神经内分泌标志物及下游靶点,神经内分泌标志物表达与免疫检查点阻断敏感性免疫特征呈负相关,ASCL1亚型有独特抗体药物偶联物靶点。
要点
- ASCL1、NEUROD1和POU2F3定义三种SCBC分子亚型,类似小细胞肺癌亚型。
- ASCL1和NEUROD1亚型高表达神经内分泌标志物,分别富集FOXA2和HES6。
- 神经内分泌标志物表达与免疫检查点阻断敏感性免疫特征呈负相关。
核心结论
- SCBC存在由ASCL1、NEUROD1和POU2F3定义的三种分子亚型,为开发新治疗方案提供见解。
研究设计与样本
- 研究分析小细胞/神经内分泌膀胱癌(SCBC)中谱系特异性转录因子定义的分子亚型。
主要发现
- ASCL1和NEUROD1亚型高表达神经内分泌标志物,分别富集不同下游调节因子FOXA2和HES6。
- ASCL1与控制致癌Notch信号的delta样配体表达相关。
- POU2F3靶向TRPM5、SOX9和CHAT。
- 神经内分泌标志物表达与免疫检查点阻断敏感性免疫特征呈负相关。
- ASCL1亚型具有临床可用抗体药物偶联物的独特靶点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Small cell/neuroendocrine bladder cancers (SCBCs) are rare and highly aggressive tumors that are associated with poor clinical outcomes. We discovered that lineage-specific transcription factors (ASCL1, NEUROD1, and POU2F3) defined three SCBC molecular subtypes that resemble well-characterized subtypes in small cell lung cancer. The subtypes expressed various levels of neuroendocrine (NE) markers and distinct downstream transcriptional targets. Specifically, the ASCL1 and NEUROD1 subtypes had high NE marker expression and were enriched with different downstream regulators of the NE phenotype (FOXA2 and HES6, respectively). ASCL1 was also associated with the expression of delta-like ligands that control oncogenic Notch signaling. POU2F3, a master regulator of the NE low subtype, targeted TRPM5, SOX9, and CHAT. We also observed an inverse association between NE marker expression and immune signatures associated with sensitivity to immune checkpoint blockade, and the ASCL1 subtype had distinct targets for clinically available antibody-drug conjugates. These findings provide new insight into molecular heterogeneity in SCBCs with implications for the development of new treatment regimens. PATIENT SUMMARY: We investigated the levels of different proteins in a specific type of bladder cancer (small cell/neuroendocrine; SCBC). We could identify three distinct subtypes of SCBC with similarity to small cell/neuroendocrine cancers in other tissues. The results may help in identifying new treatment approaches for this type of bladder cancer.
引用
- Feng M, Matoso A, Epstein G, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. 2023. PMID: 37380560. doi:10.1016/j.eururo.2023.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。